Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02374138
Other study ID # 5819
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2015
Est. completion date May 2017

Study information

Verified date August 2019
Source Children's Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when indicated for persistent or uncontrolled asthma, is a critical component of most asthma management plans, and other self-management practices such as trigger avoidance are similarly related to improved asthma outcomes. Adherence to self-management practices is mediated by multiple factors, including psychosocial stress of parents and their children.

A targeted, culturally appropriate intervention to manage psychosocial stress among the parents of young, African American, and socioeconomically disadvantaged urban children with asthma who are receiving guideline-based care may improve asthma self-management, and therefore asthma outcomes.

Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional, culturally appropriate and community-based asthma intervention to augment existing guideline-based best practice. The intervention will target the parents of at-risk, urban, African American youth, and will employ individualized psychosocial stress management and peer support.


Description:

Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when indicated for persistent or uncontrolled asthma, is a critical component of most asthma management plans, and other self-management practices such as trigger avoidance are similarly related to improved asthma outcomes. Adherence to self-management practices is mediated by multiple factors, including psychosocial stress of parents and their children.

A targeted, culturally appropriate intervention to manage psychosocial stress among the parents of young, African American, and socioeconomically disadvantaged urban children with asthma who are receiving guideline-based care may improve asthma self-management, and therefore asthma outcomes.

Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional, culturally appropriate and community-based asthma intervention to augment existing guideline-based best practice. The intervention will target the parents of at-risk, urban, African American youth, and will employ individualized psychosocial stress management and peer support.

We will conduct a single blind, prospective randomized controlled trial comparing the IMPACT DC Asthma Clinic's existing intervention of guideline-based clinical care, education, and short-term care coordination (usual care) to usual care plus parental stress management in a cohort of up to 200 parent-child dyads of AA youth aged 4-12 years.


Recruitment information / eligibility

Status Completed
Enrollment 217
Est. completion date May 2017
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group 4 Years to 12 Years
Eligibility We plan to enroll parent-child dyads that meet the following criteria:

Inclusion criteria (Parent):

- self-identify as African-American

- both the legal guardian and primary asthma caregiver of an eligible child.

Exclusion criteria (Parent):

- unable or unwilling to sign informed consent document

- exclusionary psychiatric condition, including but not limited to psychosis, based on the screening form at recruitment

- enrolled in another asthma research study.

Inclusion criteria (Child):

- parent-identified as African-American

- age 4-12 years inclusive at recruitment

- physician diagnosis of persistent asthma

- publicly financed insurance

Exclusion criteria (Child):

- chronic medical condition (other than asthma) including but not limited to diabetes, sickle cell disease, heart disease, lung disease or neurological disorder.

In addition, the PI may choose to not include a participant if he does not believe it is in the family's best interest to participate.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Parental stress management
The intervention for this study is a multi-dimensional stress management program designed to be responsive to parent and other stakeholder preferences. The intervention will have two separate yet coordinated components: one-on-one stress management sessions and peer group sessions led by "community wellness coaches."
Other:
Usual Care
IMPACT DC Asthma Clinic intervention of guideline-based clinical care, education, and short-term care coordination

Locations

Country Name City State
United States Children's National Medical Center Washington District of Columbia

Sponsors (2)

Lead Sponsor Collaborator
Stephen J. Teach, MD, MPH Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Sociodemographics Age, gender, race, ethnicity, insurance type, parental education, household income, family medical history Baseline
Other Number of Participants With Positive Smoke Exposure Participants with environmental smoke exposure. Responses were regrouped as negative (none) or positive (daily, often, or rarely) based on two questions: "How often did anyone smoke inside the home where child usually lives?" or "How often did anyone smoke in the room where child usually sleeps?" A positive response on either or both questions was considered positive exposure. Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Other Parental Health Literacy Single Item Literacy Screener (SILS) Baseline
Other Use of Existing Ancillary Services Assessed at 6m and 12m following enrollment
Other Parental Resilience Parental resilience assessed by score on Revised Life Orientation Test (LOT-R) measure. The LOT-R assesses optimism/resilience, and is comprised of 10 questions. Scores range from 0-40, with a higher score indicating a higher level of optimism. Baseline
Other Intervention Component Uptake Completion of intervention sessions 6 month intervention period
Other Intervention Satisfaction Brief survey of satisfaction with intervention components. 6 month intervention period
Other Intervention Fidelity Checklist of staff's fidelity to individual components of intervention protocol 6 month intervention period
Primary Symptom-free Days in the Last 14 Days Symptom-free days are defined as a 24-hour period with no coughing, wheezing, chest tightness, or shortness of breath and no need for rescue medications Repeated Measures at 6 months (3 month data collected to allow for repeated measures)
Secondary Asthma Morbidity - Nighttime Asthma Symptoms Nights of asthma symptoms in prior 14d Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Asthma Severity and Control Repeated Measures at 3, 6, and 12 months
Secondary Asthma Medication Adherence Reported use of inhaled corticosteroids and LTRA in past two days Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Health Care Utilization - Emergency Department Visits for Asthma Health care utilization - emergency department visits for asthma over six month and twelve month follow up periods. Reported as those documented in the electronic medical record of Children's National Health System plus parent report of visits elsewhere 12 months after enrollment
Secondary Asthma Exacerbations - Courses of Systemic Steroids Courses of systemic steroids over 12m follow up period Assessed at 6m and 12m following enrollment
Secondary Parental Stress Score on Perceived Stress Scale (PSS). The Perceived Stress Scale consists of 10 questions and is a measure of the degree to which situations in one's life are appraised as stressful. Scores range from 0 - 40, with higher scores indicating a higher level of perceived stress. Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Parental Depression Score on Center for Epidemiologic Studies Depression Scale (CES-D - 10). The CESD-10 scale screens for depressive symptoms. Scores range from 0-30, with higher scores indicating a higher degree of depressive symptoms. Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Child Anxiety PROMIS Parent Proxy Anxiety. For PROMIS instruments, T-scores rescale the raw score into a standardized score with a mean of 50 and a standard deviation of 10. A higher T-score represents higher anxiety and/or depression. Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Child Depression PROMIS Parent Proxy Depressive Symptoms is a parent-report assessment of child depression. For PROMIS instruments, T-scores rescale the raw score into a standardized score with a mean of 50 and a standard deviation of 10. A higher T-score represents higher anxiety and/or depression. Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Caregiver Quality of Life Caregiver quality of life score, assessed by modified Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ). The measure had five response options, with scores ranging from 13-65 and higher scores meaning better quality of life. No subscales were analyzed. Repeated Measures at 6 and 12 months (3m data collected for repeated measures)
Secondary Number of Participants With AEs and SAEs Safety data: Number of Participants with AEs and SAEs 12m follow up period
Secondary Economic Outcomes Analysis of costs of care in both groups 12m follow-up period
Secondary Caregiver Smoking Behavior parent report of cigarettes smoked per day Repeated Measures at 6 and 12 months
Secondary Coping Strategies Brief COPE Repeated measures at 12m FU (6m data used for repeated measures)
Secondary Mindfulness Interpersonal Mindfulness in Parenting Repeated Measures at 6 and 12 months
Secondary Parental Resilience Parental resilience assessed by score on Revised Life Orientation Test (LOT-R) measure. The LOT-R assesses optimism/resilience, and is comprised of 10 questions. Scores range from 0-40, with a higher score indicating a higher level of optimism. Repeated Measures at 6 and 12 months
Secondary Exacerbations - Hospital Admissions Number of participants with hospital admissions due to exacerbations Assessed at 6m and 12m after enrollment
Secondary Symptom-free Days in the Last 14 Days Symptom-free days are defined as a 24-hour period with no coughing, wheezing, chest tightness, or shortness of breath and no need for rescue medications Repeated Measures at 12 months (with data also assessed at 3m and 6m)
Secondary Asthma Morbidity - Daytime Asthma Symptoms, Days of Activity Limitations, and Days of Quick Relief Medicine Use Days of asthma symptoms, activity limitation, and quick relief medicine use in prior 14d Repeated measures at 6 and 12 months (3m data collected for repeated measures)
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device